drugset / Trial / NCT03964688
Effect of Vitamin C in Autologous Stem Cell Transplantations
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In the study the investigators will randomize patients that receive an autologous stem cell transplantation for myeloma or lymphoma for treatment with vitamin C or placebo during 6 weeks. Primary endpoint will be immune recovery.
Timeline
- Start
- 2019-12-10
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | — | Intravenous |